MPTP hydrochloride is used as a pharmaceutical intermediate; it is a dopaminergic neurotoxin widely employed to induce Parkinson’s disease-like symptoms in animal models by selectively destroying dopaminergic neurons; it is commonly used in both in vitro and in vivo studies to investigate mechanisms of neurodegeneration, apoptosis, tau phosphorylation, and α-synuclein accumulation associated with Parkinson’s disease.